Tyra Biosciences TYRA Cash Flow Statement (2020-2026)

NASDAQ TYRA
$20.60 +0.13 (+0.64%)
At close: Oct 21, 2026 · 4:00 PM EDT
Reported Financials

Tyra Biosciences Quarterly Cash Flow Statement

Periods 24 quarters
Latest Jun 2026

Tyra Biosciences reported cash from operations of -$31.08M and free cash flow of -$31.14M for the quarter ended Jun 2026, down 31.2% year over year. This cash flow statement covers 24 quarters of results from Sep 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-6.64M-9.93M-14.83M-15.10M-12.51M-12.90M-11.88M-13.27M-21.15M-22.83M-18.19M-18.70M-24.02M-25.57M-28.15M-28.10M-29.87M-33.83M-39.31M-45.56M
Depreciation and DepletionDep. & Depletion
41.00M-89.86M0.06M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
0.04M0.05M0.06M0.07M0.08M0.08M0.08M0.09M0.08M0.10M0.12M0.13M0.13M0.14M0.14M0.14M0.13M0.13M0.14M0.14M
Share-based CompensationStock Comp.
0.51M1.87M3.97M2.69M1.02M2.91M2.43M2.53M4.38M4.19M2.70M4.41M7.57M6.70M6.42M6.38M7.58M7.63M7.85M10.23M
Gains from Sales and DivestituresGains Divest
0.00M0.00M0.00M0.00M0.00M
Change in Working Capital
Change in Accured ExpensesChange Accured Exp.
1.23M0.10M1.56M0.54M0.05M0.21M-2.02M1.67M4.64M5.08M-6.91M1.94M2.01M2.21M-0.37M-0.49M2.07M2.16M1.20M5.32M
Change in Other Operating AssetsOther Assets Change
0.76M1.19M-0.30M5.38M0.86M2.29M-1.53M0.19M5.25M-1.09M0.04M-3.80M2.02M1.91M2.67M0.93M1.89M-0.40M2.44M1.02M
Other Working Capital ChangesOther WC Changes
-0.05M-0.08M0.00M-0.01M-0.01M-0.01M-0.01M0.44M-0.15M-0.09M-0.11M-0.03M-0.03M-0.02M-0.02M-0.03M-0.02M-0.02M-0.02M-0.02M
Cash from OperationsCash from Ops.
-5.58M-9.03M-8.93M-17.17M-12.21M-11.98M-9.85M-9.62M-17.15M-13.53M-22.03M-10.26M-17.90M-19.59M-25.46M-23.68M-22.38M-23.62M-32.57M-31.08M
Investing Activities
Capital ExpendituresCapex
0.26M0.11M0.24M0.25M0.05M0.02M0.04M0.04M0.08M0.60M0.14M0.47M0.05M0.01M0.01M0.03M0.04M0.06M0.09M0.07M
Change in Property, Plant and EquipmentChange in PP&E
-0.26M-0.11M-0.24M-0.25M-0.05M-0.02M-0.04M-0.04M-0.08M-0.60M-0.14M-0.47M-0.05M-0.01M-0.01M-0.03M-0.04M-0.06M-0.09M-0.07M
Purchase of InvestmentsInvestments Purchased
143.84M11.79M177.41M36.39M38.04M6.87M20.11M65.17M9.11M162.21M22.08M
Sale and Maturity of InvestmentsInvestments Sold
30.00M32.89M58.00M45.00M38.91M41.00M50.41M43.54M42.05M40.00M
Cash from Investing ActivitiesCash from Investing
-0.24M-0.11M-0.24M-0.25M-0.05M-0.02M-0.04M-0.04M-0.08M-144.44M18.07M-144.99M21.56M6.96M32.03M20.87M-14.81M34.38M-120.24M17.85M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt RepaymentsLT Debt Repayment
Non-Current Debt
Net Debt Issuances and RepaymentsNet Debt Issuance
Change in Capital Stock
Common Stock IssuedStock Issued
-2.05M147.85M
Net Shares Issued and RepurchasedNet Shares Issued
-2.05M147.85M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
-2.05M147.85M
Other financing activitiesOther financing
183.46M-2.10M
Cash from Financing ActivitiesCash from Financing
183.44M-1.51M0.24M0.03M0.36M0.00M0.38M0.37M0.47M0.32M200.32M0.37M0.74M0.71M2.19M0.58M0.65M4.68M160.38M2.10M
Additional items
Change in Cash
177.62M-10.64M-8.93M-17.39M-11.90M-12.00M-9.51M-9.29M-16.76M-157.65M196.36M-154.88M4.40M-11.93M8.76M-2.23M-36.54M15.44M7.57M-11.12M
Ending Cash Balance
313.07M302.43M293.50M276.11M264.21M252.21M242.70M233.41M216.65M59.01M100.49M104.89M92.97M78.39M
Free Cash FlowFCF
-5.83M-9.13M-9.16M-17.42M-12.26M-12.00M-9.89M-9.66M-17.23M-14.14M-22.16M-10.73M-17.95M-19.60M-25.47M-23.71M-22.42M-23.68M-32.66M-31.14M
Net Cash FlowNCF
177.62M-10.64M-8.93M-17.39M-11.90M-12.00M-9.51M-9.29M-16.76M-157.65M196.36M-154.88M4.40M-11.93M8.76M-2.23M-36.54M15.44M7.57M-11.12M

Tyra Biosciences Cash Flow Statement API

Pull Tyra Biosciences's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=TYRA&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY